top of page

Spotlight: June-August 2022

Updated: Sep 14, 2022

Words by Jade Williams

GOLD looks back at some of the top news stories from the pharmaceutical industry over the last few months, covering recent collaborations, drug approvals and much more

08 June

Gilead Sciences and Westminster Drug Project repartner to eliminate hepatitis C in drug and alcohol services by end of 2023

14 June

Merck and the Mulliken Centre enter three-year collaboration for machine learning project

20 June

University of Manchester researchers discover blood vessel link to halt Alzheimer’s progression

23 June

Novartis renews Kigali Declaration commitment, investing $250m over five years for neglected tropical diseases

30 June

Pfizer announces commitment to reach Net-Zero Standard ahead of schedule by 2040

05 July

Juvisé Pharmaceuticals completes €400m refinancing after acquiring rights to antimicrobial Pylera

12 July

ABPI sets new NHS data usage regulations for pharma companies

18 July

Long-awaited Haleon demerger completed by GSK

25 July

EC extends Bavarian Nordic’s Imvanex smallpox vaccine license to tackle monkeypox

28 July

GSK signs agreement to supply pandemic influenza vaccine Adjupanrix to 12 European countries

02 Aug

CSL Limited receives regulatory clearances to acquire Vifor Pharma, with Hervé Gisserot appointed as General Manager

04 Aug

Sanofi and Innovent Biologics collaborate to accelerate development of oncology medicines and expand presence in China

This article features in GOLD 23 – read the full issue here.

bottom of page